Digital breast tomosynthesis vs digital mammography -- and more news

Tuesday, August 25, 2020

News for the week of August 24, 2020.

  1. Beyond baseline, DBT no better than mammography for dense breasts: https://bit.ly/2FTRnpp
    Study source: https://bit.ly/2FTLkkI
    Lead author: https://bit.ly/3graAv0
  2. Subgroups predict adjuvant chemoradiotherapy benefits in low-grade glioma: https://bit.ly/31oHkkr
    Source: https://bit.ly/3aSVe1j
  3. Diabetes plus weight loss equals increased risk of pancreatic cancer: https://bit.ly/2Etmbws
    Source: https://bit.ly/2EyRBkV

For more MDedge podcasts: htttps://www.mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Podcast Participants

David Henry, MD
David Henry, MD, FACP, is a clinical professor of medicine at the University of Pennsylvania and vice chairman of the department of medicine at Pennsylvania Hospital in Philadelphia. He received his bachelor’s degree from Princeton University and his MD from the University of Pennsylvania, then completed his internship, residency, and fellowship at the Hospital of the University of Pennsylvania. After 2 years as an attending in the U.S. Air Force, he was drawn to practicing as a hem-onc because of the close patient contact and interaction, and his belief that, win or lose with each patient, one can always make a difference in their care and lives. Follow Dr. Henry on Twitter: @davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.